Fannin Innovation Studio

@FanninStudio

Partnering with life science innovators to co-found startup companies by providing a shared management team, central office space and seed funding

Houston, Texas fannininnovation.com Joined November 2014

372 Following 685 Followers 703 Posts

Latest posts 5

Fannin Innovation Studio @FanninStudio Dec 18, 2020

Congratulations to Allterum for completing its $1.8 million Series Seed offering and its new phase of growth right before the new year! Read more: lnkd.in/e4ua7RM

#innovation #healthcare #cancer #research #houtech @bcmhouston @TexasChildrens @ChildrensPhila @CPRITTexas

lnkd.in LinkedIn This link will take you to a page that’s not on LinkedIn

Fannin Innovation Studio @FanninStudio Dec 3, 2020

Via @Rojelio Mejia, MD. Thank you for the tweet! Great innovations happen with amazing collaborators!

#innovation #science #Medical #research #ThursdayThoughts @BCM_TropMed @mebottazzi
@PeterHotez @brevitest @varadhachary @DevBreviTest #Houston #Entrepreneurship #technology

Rojelio Mejia, MD Verified account @Rojelio Dec 2, 2020

Also ran our first recombinant Toxocara serology on the fantastic Brevitest device. Easy to use, results in 10 minutes, and highly sensitive and specific! The people @FanninStudio @brevitest continue to amaze with their innovations!

View quoted post on X

Fannin Innovation Studio @FanninStudio Dec 3, 2020

Join us tonight for the Virtual 6th Annual Evening of Pediatric Device Innovation Symposium. Presented by Southwest National Pediatric Device Innovation Consortium & @JLABS - TMC. Free Registration: lnkd.in/eCcmqYN
#thursdayvibes #innovation #Science #technology #health

Fannin Innovation Studio @FanninStudio Nov 16, 2020

Brevitest is looking for a Director of Clinical Operations & Regulatory Affairs! Great opportunity for anyone with 10+ years’ experience in the regulatory/clinical operations field. Learn more: lnkd.in/gBSiTxc

#Biotechnology #science #jobsearch #tech #medical #innovation

Fannin Innovation Studio @FanninStudio Oct 6, 2020

Allterum announces that the FDA has granted Orphan Drug Designation & Rare Pediatric Disease Designation for its antibody therapy in development for #pediatric acute lymphoblastic #leukemia. story.cd/AAO7En

@CPRITTexas @theNCI #TuesdayThoughts #pharma #science #biotech